Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Ugeskrift for Laeger|March 7, 2001
[Prevention of thrombosis in hip alloplasty]L C Borris, M B Petersen, M R Lassen
Thrombosis|November 16, 2011
Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee ReplacementLars C Borris, Morten Breindahl, Michael R Lassen, et al.
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryB I Eriksson, K A Bauer, M R Lassen, et al.
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryK A Bauer, B I Eriksson, M R Lassen, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|November 18, 2021
Patient motivation in group metacognitive therapy for generalized anxiety disorderEspen R Lassen, Mourad Touil, Tone L Svendsen, et al.
Clinical Orthopaedics and Related Research|June 20, 2008
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplastyBengt I Eriksson, Richard J Friedman, Fred D Cushner, et al.
Journal of the Southern Orthopaedic Association|February 25, 2003
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialistKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.
Archives of Internal Medicine|August 28, 2002
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studiesAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Lancet (London, England)|November 15, 2003
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgeryAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Current Opinion in Pulmonary Medicine|August 13, 2002
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolismKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Ugeskrift for Laeger|March 7, 2001
[Prevention of thrombosis in hip alloplasty]L C Borris, M B Petersen, M R Lassen
Thrombosis|November 16, 2011
Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee ReplacementLars C Borris, Morten Breindahl, Michael R Lassen, et al.
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryB I Eriksson, K A Bauer, M R Lassen, et al.
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryK A Bauer, B I Eriksson, M R Lassen, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|November 18, 2021
Patient motivation in group metacognitive therapy for generalized anxiety disorderEspen R Lassen, Mourad Touil, Tone L Svendsen, et al.
Clinical Orthopaedics and Related Research|June 20, 2008
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplastyBengt I Eriksson, Richard J Friedman, Fred D Cushner, et al.
Journal of the Southern Orthopaedic Association|February 25, 2003
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialistKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.
Archives of Internal Medicine|August 28, 2002
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studiesAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Lancet (London, England)|November 15, 2003
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgeryAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.
Current Opinion in Pulmonary Medicine|August 13, 2002
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolismKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.
Pageof 14